Together, these data suggest the involvement of AP1, TGFβ, YAP/TAZ, serotonin and VEGF signaling in PAH, resulting in inflammation, EndMT, vascular stiffness and aberrant angiogenesis. Here, TGFB1 is linked to pulmonary arterial hypertension.